No association between an interleukin 4 gene promoter (-589) polymorphism and Graves' disease in Thai patients

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Nakkuntod, Jeerawat ^a   Wongsurawat, Thidathip ^a   Charoenwongse, Preeyachit ^a   Snabboon, Thiti ^a   Sridama, Vittaya ^a   Hirankarn, Nattiya ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Graves' disease; Interleukin 4

Indexed keywords

INTERLEUKIN 4;

ARTICLE; ASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROMOTER REGION; THAILAND;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GRAVES DISEASE; HUMANS; INTERLEUKIN-4; MALE; PROMOTER REGIONS (GENETICS); THAILAND;

EID: 22744441323     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dogan RN, Vasu C, Holterman MJ, Prabhakar BS. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 2003; 170: 2195-204.
2. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-40.
3. Davies TF. Autoimmune thyroid disease genes come in many styles and colors. J Clin Endocrinol Metab 1998; 83: 3391-3.
4. Gough SC. The genetics of Graves' disease. Endocrinol Metab Clin North Am 2000; 29: 255-66.
5. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001; 86: 930-4.
6. Jin Y, Teng W, Ben S, Xiong X, Zhang J, Xu S, et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J Clin Endocrinol Metab 2003; 88: 1798-803.
7. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, et al. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 2001; 86: 626-30.
8. Tomer Y, Davies TF. The genetic susceptibility to Graves' disease. Baillieres Clin Endocrinol Metab 1997; 11: 431-50.
9. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet 1998, 63: 1749-56.
10. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, et al. Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease. Am J Hum Genet 1999; 65: 1462-5.
11. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, et al. Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Genet 2000; 66: 1710-4.
12. Maalej A, Makni H, Ayadi F, Bellassoued M, Jouida J, Bouguacha N, et al. A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders. Genes Immun 2001; 2: 71-5.
13. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999; 8: 1195-9.
14. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 1998; 352: 866-70.
15. Brix TH, Kyvik KO, Hegedus L. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 1998; 8: 727-34.
16. Ajjan RA, Watson PF, Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol 1996; 6: 359-86.
17. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997; 82: 666-9.
18. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
19. Natt N, Bahn RS. Cytokines in the evolution of Graves' ophthalmopathy. Autoimmunity 1997; 26: 129-36.
20. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K. Interferon-gamma gene micro-satellite polymorphisms in patients with Graves' disease. Thyroid 1998; 8: 1013-7.
21. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52: 759-64.
22. Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, et al. Tumor necrosis factor beta gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 1992; 74: 287-91.
23. Blakemore AI, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-5.
24. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995; 15: 121-9.
25. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
26. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990; 127: 357-61.
27. Weetman AP, Freeman M, Morgan BP. Thyroid follicular cell function after non-lethal complement membrane attack. Clin Exp Immunol 1990; 82: 69-74.
28. Weetman AP, Black CM, Cohen SB, Tomlinson R, Banga JP, Reimer CB. Affinity purification of IgG subclasses and the distribution of thyroid autoantibody reactivity in Hashimoto's thyroiditis. Scand J Immunol 1989; 30: 73-82.
29. Kuppers RC, Outschoorn IM, Hamilton RG, Burek CL, Rose NR. Quantitative measurement of human thyroglobulin-specific antibodies by use of a sensitive enzyme-linked immunoassay. Clin Immunol Immunopathol 1993; 67: 68-77.
30. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87-99.
31. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180: 1961-6.
32. Kantarci OH, Schaefer-Klein JL, Hebrink DD, Achenbach SJ, Atkinson EJ, McMurray CT, et al. A population-based study of IL4 polymorphisms in multiple sclerosis J Neuroimmunol 2003; 137: 134-9.
33. Vandenbroeck K, Goris A. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci 2003; 24: 284-9
34. Walley AJ, Cookson WO. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996; 33: 689-92.
35. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy Clin Exp Allergy 1995;25 Suppl 2: 74-8; discussion 95-6
36. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene J Immunol 1996; 156: 424-9.
37. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-8.
38. Heward JM, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn JA, Gough SC. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab 2001; 86: 3861-3.
39. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
40. Michel J, Gonzales JR, Wunderlich D, Diete A, Herrmann JM, Meyle J. Interleukin-4 polymorphisms in early onset periodontitis. J Clin Periodontol 2001; 28: 483-8.
41. Kabesch M, Tzotcheva I, Carr D, Hofler C, Weiland SK, Fritzsch C, et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003; 112: 893-8.
42. Gibson G. Population genomics: finding the variants of mass disruption. Curr Biol 2003; 13: R901-3.
43. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA. Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol 2003; 13: 2118-23.